UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This overview explains risk parity investing and how allocating risk rather than capital can influence retirement portfolio stability.
26,641 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Mortgage applications fall 2.3% last week as borrowing costs move higher, signaling a cooling in home-purchase activi...
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
Tesla’s stock price problem remains in focus as shares hover in a tight range amid mixed demand data and bets on AI v...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....
atlas vms’s erik morin outlines how second appraisals for HECMs affect borrowers and lenders as an AIM-Port deal gain...
Mexico’s president confirms that the U.S. requested Iran’s World Cup training base move to Tijuana, as the 2026 tourn...
NASA awarded the first phase of its moon base contracts to four U.S. companies, signaling a major shift in private-pu...
Senator Cynthia Lummis warns that failing to advance the CLARITY Act could push U.S. crypto policy toward a regulator...
CoinGecko data show wallets, bots, and trading interfaces funnel trades into HyperCore, turning the hyperliquid build...
Micron Technology posted a robust quarter fueled by AI infrastructure spending, signaling a multi-year path for this ...
A mobile platform that pays users to scroll is gaining momentum as it cracks Deloitte’s fastest-growing software rank...